DCGI approves Phase II+III trials of Oxford Uni vaccine by Serum Institute
GN Bureau | August 4, 2020
As part of its 3T strategy of focusing on testing, tracing and treating to contain the Covid-19 pandemic, India crossed a landmark, testing 2,02,02,858 COVID-19 samples so far.
This is pursuant to the key strategy followed by state/UT governments under the guidance of the centre for management of Covid-19 to “Test aggressively, Track efficiently and Isolate and Treat promptly", the health ministry said in a release Monday. Effective implementation of this approach has led to ramping up the testing capacity across the country and facilitated widespread Covid testing of people.
With 3,81,027 samples tested in the 24 hours to Monday evening, the number of tests per million (TPM) has increased to 14,640. While the country's TPM has demonstrated a steady upward trend indicating the growing testing network, 24 states and UTs have reported higher testing per million than the national average.
The testing lab network in the country is continuously strengthened with 1,348 labs in the country; 914 labs in the government sector and 434 private labs.
Meanwhile, the Drugs Controller General of India (DCGI) has given approval to Serum Institute of India, Pune, to conduct Phase II+III clinical trials of Oxford University-Astra Zeneca Covid-19 vaccine (COVISHIELD) in India. This will hasten the development of the Covid-19 vaccine.
Case Fatality Rate improves
India continues to improve the Case Fatality Rate (CFR), and maintain its global position of having one of the lowest Covid fatalities rates. With a further fall, the CFR touched 2.11% Monday. This is the outcome of the well conceived and effectively implemented strategy of "Test, Track and Treat" which has guided the Covid management in the country.
The management strategy of Covid-19 also focuses on early detection and isolation of cases with seamless patient management and prioritising care of the high-risk population using field health care workers leading to increase in recoveries across the country. India has seen more than 40,574 patients recovered in the 24 hours to Monday evening. This takes the total recoveries to 11,86,203 and Recovery Rate to 65.77% amongst Covid-19 patients.
With improving daily recovery number, the gap between the recovered cases and the active cases has increased to more than 6 lakh. Currently, it is 6,06,846. This means the actual active case load is 5,79,357 and all are under medical supervision.
The Art of Conjuring Alternate Realities: How Information Warfare Shapes Your World By Shivam Shankar Singh and Anand Venkatanarayanan HarperCollins / 284 pages / Rs 599 Professor Noam Chomsky, linguist and public intellectual, has often spoken of &ls
The brutal second wave of the COVID-19 pandemic in India has left a significant death toll in its wake. Health experts advise that the imminent third wave can be delayed by following simple measures like wearing a mask and engaging in social distancing. However, near the end of the second wave, we witnesse
Union Minister of Road Transport and Highways Nitin Gadkari has emphasised deciding driving hours for truck drivers of commercial vehicles, similar to pilots, to reduce fatigue-induced road accidents. In a Na
In a step towards Telecom Reforms which aim to provide internet and tele connectivity for the marginalised section, the Department of Telecommunications, Ministry of Communica
Raising concerns over rising seawater levels and climate change, Mumbai First, a 25-year-old public-private partnership policy think tank, has written letters to Maharashtra chief minister Uddhav Thackeray, minister for environment and climate change, tourism and protocol, Aditya Thackeray and Mumbai munic
After the recent announcement of the government guarantee for Security Receipts (SRs) to be issued by a public sector-owned National Asset Reconstruction Company Ltd (NARCL), there is a surge of interest around this desi version of a super bad bank. The entity will acquire around ₹2 trillion bad debts fr